Is Structure Therapeutics Inc. (GPCR) a Buy, Sell, or Hold?
Structure Therapeutics Inc.
NASDAQ:GPCR
$50.59 USD
-$1.05 (-2.03%)
- Volume
- 565.86K
- Average Volume
- 825.29K
- Market Capitalization
- $2.91B
- P/E Ratio
- -19.16
- Dividend Yield
- 0.00%
- Price Target
- $102.00
- Year High
- $94.90
- Year Low
- $15.80
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $26.16
Analyst Rating
Sell
2 Rating Score
UPSIDE/DOWNSIDE
-50.4% DOWNSIDE
$102.00 Price Target
UPSIDE/DOWNSIDE HIGH
-65.1% DOWNSIDE
$145.00 Price Target High
UPSIDE/DOWNSIDE LOW
-27.7% DOWNSIDE
$70.00 Price Target Low
INSIDER TRADING
Shares
$- Last Quarter
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| H.C. Wainwright | Ananda Ghosh | $70 | $41.53 | 2026-06-11 06:42 AM | 68.6% |
| BMO Capital | Evan Seigerman | $145 | $56.8846 | 2026-03-17 08:29 AM | 154.9% |
| H.C. Wainwright | Ananda Ghosh | $90 | $66.45 | 2025-12-19 08:43 AM | 35.4% |
| Morgan Stanley | Terence Flynn | $125 | $66.235 | 2025-12-12 08:10 AM | 88.7% |
| Stifel Nicolaus | Annabel Samimy | $50 | $33.89 | 2025-12-02 09:21 AM | 47.5% |